Multistage nanoparticle delivery system for deep penetration into tumor
Current Food and Drug Administration-approved cancer nanotherapeutics, which passively accumulate around leaky regions of the tumor vasculature because of an enhanced permeation and retention (EPR) effect, have provided only modest survival benefits. This suboptimal outcome is likely due to physiolo...
Main Authors: | , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
National Academy of Sciences (U.S.),
2011-08-15T19:06:56Z.
|
Subjects: | |
Online Access: | Get fulltext |